Contact: Patricia A.  Spinella
Investor Relations
(201) 847-5453
Email: patricia_spinella@bd.com

Colleen T.  White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

Franklin Lakes, NJ (September 16, 2004) -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it would participate in the UBS Global Life Sciences Conference. The BD presentation will be made on Thursday, September 30 at 12:30 p.m. (ET).

The live webcast of BD's presentation can be accessed from the BD website at www.bd.com/investors and will be available for replay through Thursday, October 7.

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2003, BD reported total revenues of $4.528 billion.